These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 1815712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
    Tiwari RP, Jain A, Khan Z, Kumar P, Bhrigu V, Bisen PS.
    J Immunol Methods; 2013 Jan 31; 387(1-2):157-66. PubMed ID: 23098841
    [Abstract] [Full Text] [Related]

  • 4. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR, Strick N, Lee ES.
    J Gen Virol; 1990 Jan 31; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses.
    Simon F, Souquière S, Damond F, Kfutwah A, Makuwa M, Leroy E, Rouquet P, Berthier JL, Rigoulet J, Lecu A, Telfer PT, Pandrea I, Plantier JC, Barré-Sinoussi F, Roques P, Müller-Trutwin MC, Apetrei C.
    AIDS Res Hum Retroviruses; 2001 Jul 01; 17(10):937-52. PubMed ID: 11461679
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Depletion in antibodies targeted to the HR2 region of HIV-1 glycoprotein gp41 in sera of HIV-1-seropositive patients treated with T20.
    Vincent N, Tardy JC, Livrozet JM, Lucht F, Frésard A, Genin C, Malvoisin E.
    J Acquir Immune Defic Syndr; 2005 Mar 01; 38(3):254-62. PubMed ID: 15735441
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M, Dickey C, Cotropia JP, Gevorkian G, Larralde C, Broliden K, Levi M, Burgess A, Cao C, Weiner DB, Agadjanyan MG, Ugen KE.
    Virology; 2000 Apr 25; 270(1):135-45. PubMed ID: 10772986
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
    Madaule P, Gairin JE, Bénichou S, Rossier J.
    FEMS Microbiol Immunol; 1991 Apr 25; 3(2):99-107. PubMed ID: 1713777
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of gp41 antigens by enzyme-linked immunosorbent assays for detecting antibodies to human immunodeficiency virus type 1.
    Zweig M, Bladen SV, Dubois GC, Samuel KP, Showalter SD, Papas TS.
    AIDS Res Hum Retroviruses; 1988 Dec 25; 4(6):487-92. PubMed ID: 3265329
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.